While it is imperative to emphasize that our research has dug the underlying pathway about SLC6A19 and identified a robust correlation between this gene and fatty acid metabolism in ccRCC, which was initially uncovered through GSEA and further substantiated by subsequent experimental validations. This evidence concerns the gene SLC6A19 and nonpapillary renal cell carcinoma.